Blood draw and tissue collection for men and women ages 19-80 who have, or are suspected of having Colorectal cancer. Patient should have surgery pending or scheduled.
We have a number of Pulmonary Hypertension studies that are ongoing. But due to the nature of these trials please contact us if you are interested in participating.
Single Blood draw for women 10-26 months pregnant Urine collection for women ages 18-40, who are 1-9 months pregnant Urine collection for non-pregnant women 18-40
Neurology Trial: 36 week study phase 2 study to assess the effect of drug on functional decline in subjects with ALS
INCLUSION: Male/ Female 18-75 years of age Clinically definite, laboratory probable, or clinically probable ALS ALS symptom onset < 2 years prior to screening visit Subjects on riluzole may enter the study if they have been on a stable dose of 50mg BID for >4 weeks prior to screening visit. EXCLUSION: Subject has participated in […]
Neurology Trial: 16 week study designed to assess the effect of the drug versus placebo on respiratory function with patients with ALS
INCLUSION: Male/Female 18-80 years of age Sporadic or familial ALS <24 months prior to screening SVC > 65% of predicted for age/height/sex EXCLUSION: At time of screening any use of non-invasive ventilation Neurological impairment due to a condition other than ALS Presence at screening of any medically significant cardiac, pulmonary, gastrointestinal, musculoskeletal, or psychiatric illness […]
Neurology Trial: 28 Week study designed to test efficacy of a fixed combination of drugs for the treatment of ALS
INCLUSION: Male/Female 18-80 years of age Sporadic or familial ALS Less than or equal to 18 months since ALS symptom onset. Slow Vital Capacity >60% of predicted value for gender/height/age at screening EXCLUSION: Presence of tracheostomy Exposure to PB/ TUDCA, or UDCA within 3 months prior to the Screening visit
Asthma Trial: Observational study of patients with a diagnosis of asthma and/or COPD (observation period of 3 years)
a. Subjects ≥12 years of age with a confirmed or suspected diagnosis of asthma or COPD b. Observational study only (no study medications)
Asthma Trial: Pediatric 6-12 years with persistent, uncontrolled asthma (treatment period of 52 weeks)
a. Subjects 6-12 years of age with persistent asthma for at least 12 months b. At least 3 months of therapy on medium-dose inhaled corticosteroids plus a second asthma controller or high-dose inhaled corticosteroids alone c. One or more asthma exacerbations in the previous 12 months requiring treatment with systemic corticosteroids
a. Subjects 18-75 years of age with severe asthma requiring medium to high-dose inhaled corticosteroids plus a second asthma controller in the previous 12 months b. Two or more asthma exacerbations in the previous 12 months requiring treatment with systemic corticosteroids c. Pre-screening FEV1 <80% of predicted d. Current smokers and ex-smokers with >10 pack-year […]
a. Subjects ≥12 years of age with severe asthma requiring medium to high-dose inhaled corticosteroids plus a second or third asthma controller b. Two or more asthma exacerbations in the previous 12 months requiring treatment with systemic corticosteroids c. FEV1 of ≥40% and ≤80% (≤90% for patients aged 12-18 years) d. Current smokers and ex-smokers […]